The National Diabetes Education Program, changing the way diabetes is treated: Comprehensive diabetes care

Diabetes Care

Volumn 24, Issue 4, 2001, Pages 617-618

  Clark Jr , Charles M ^a,g   Fradkin, Judith E ^b   Hiss, Roland G ^c   Lorenz, Rodney A ^d   Vinicor, Frank ^e   Warren Boulton, Elizabeth ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^f Hagar Sharp   (United States)

^g REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE CONTROL; EDITORIAL; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HEALTH PROGRAM; PATIENT CARE; PROPHYLAXIS; RISK FACTOR; TREATMENT PLANNING;

EID: 0034834287     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.4.617     Document Type: Editorial

References (20)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
3. Diabetes and decline in heart disease mortality in US adults
4. The progressive cost of complications in type 2 diabetes mellitus
5. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
7. Management of dyslipidemia in adults with diabetes
8. Cardiovascular events and their reduction with pravastatin in diabetic and glucoseintolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) trial
9. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
11. The hypertension optimal treatment study and the importance of lowering blood pressure
12. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and the MICRO-HOPE substudy
13. Management of diabetes mellitus from a public health perspective
14. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
15. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
16. Effect of improved glycemic control on health care costs and utilization
17. Health implications of obesity
18. New insights into the metabolic regulation of insulin action and insulin resistance: Role of glucose and amino acids
19. Intentional weight loss and mortality among overweight individuals with diabetes
20. Standards of medical care for patients with diabetes mellitus